Filing metadata

Accession number
0001209191-18-064322
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Dec 28, 2018
Reporting period
Dec 26, 2018
Description
Insider transaction

Explore SEC Filings Hub